Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome

• Main Authors: Vernon Suzanne D, Nisenbaum Rosane, Unger Elizabeth R, Whistler Toni
• Format: Article
• Language: English
• Published: BMC 2003-12-01
• Series: Journal of Translational Medicine
• Online Access: http://www.translational-medicine.com/content/1/1/10

<p>Abstract</p> <p>Background</p> <p>Chronic fatigue syndrome (CFS) has no diagnostic clinical signs or diagnostic laboratory abnormalities and it is unclear if it represents a single illness. The CFS research case definition recommends stratifying subjects by co-morbid conditions, fatigue level and duration, or functional impairment. But to date, this analysis approach has not yielded any further insight into CFS pathogenesis. This study used the integration of peripheral blood gene expression results with epidemiologic and clinical data to determine whether CFS is a single or heterogeneous illness.</p> <p>Results</p> <p>CFS subjects were grouped by several clinical and epidemiological variables thought to be important in defining the illness. Statistical tests and cluster analysis were used to distinguish CFS subjects and identify differentially expressed genes. These genes were identified only when CFS subjects were grouped according to illness onset and the majority of genes were involved in pathways of purine and pyrimidine metabolism, glycolysis, oxidative phosphorylation, and glucose metabolism.</p> <p>Conclusion</p> <p>These results provide a physiologic basis that suggests CFS is a heterogeneous illness. The differentially expressed genes imply fundamental metabolic perturbations that will be further investigated and illustrates the power of microarray technology for furthering our understanding CFS.</p>